Looks like they’ve used the wrong denominator to calculate quarters of funding available (ie they used annual rather than quarterly net cash used in operating activities) - so should have been approx 4.5 quarters
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Looks like they’ve used the wrong denominator to calculate...
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
82.5¢ |
Change
0.005(0.61%) |
Mkt cap ! $1.015B |
Open | High | Low | Value | Volume |
81.5¢ | 83.0¢ | 79.5¢ | $622.4K | 765.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 43582 | 81.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
82.5¢ | 42279 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 43582 | 0.810 |
1 | 12282 | 0.805 |
2 | 20282 | 0.800 |
2 | 13539 | 0.795 |
5 | 57189 | 0.790 |
Price($) | Vol. | No. |
---|---|---|
0.825 | 22279 | 2 |
0.830 | 17715 | 3 |
0.835 | 12282 | 1 |
0.840 | 13682 | 2 |
0.845 | 20000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online